1. Avoid fenoterol

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Benzodiazepines: fear of overprescribing may have led to underprescribing …

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. … also, management of withdrawal should be patient-specific

   Newsletter Article 27 January 2013 Pages: 1 - 1

4. Patients should be monitored while receiving clomifene

   Newsletter Article 27 January 2013 Pages: 2 - 2

5. Education on antidiarrhoeal therapy is required

   Newsletter Article 27 January 2013 Pages: 2 - 3

6. Improving the safety of antiarrhythmic therapy

   Newsletter Article 27 January 2013 Pages: 3 - 3

7. Alprazolam withdrawal

   Newsletter Article 27 January 2013 Pages: 3 - 3

8. Amfebutamone

   Newsletter Article 27 January 2013 Pages: 3 - 3

9. Anticoagulants

   Newsletter Article 27 January 2013 Pages: 3 - 3

10. Anaesthetics

    Newsletter Article 27 January 2013 Pages: 4 - 4

11. Anticonvulsants

    Newsletter Article 27 January 2013 Pages: 4 - 4

12. Antineoplastics

    Newsletter Article 27 January 2013 Pages: 4 - 4

13. Benzodiazepines dependence

    Newsletter Article 27 January 2013 Pages: 4 - 4

14. Betamethasone

    Newsletter Article 27 January 2013 Pages: 4 - 4

15. Bumetanide

    Newsletter Article 27 January 2013 Pages: 4 - 4

16. Bumetanide see Lithium interaction

    Newsletter Article 27 January 2013 Pages: 4 - 4

17. Canthaxanthin

    Newsletter Article 27 January 2013 Pages: 4 - 4

18. Captopril

    Newsletter Article 27 January 2013 Pages: 4 - 5

19. Carbetimer

    Newsletter Article 27 January 2013 Pages: 5 - 5

20. Carboplatin

    Newsletter Article 27 January 2013 Pages: 5 - 5

21. Chlormustine

    Newsletter Article 27 January 2013 Pages: 5 - 5

22. Chlorpromazine see Haloperidol/chlorpromazine

    Newsletter Article 27 January 2013 Pages: 5 - 5

23. Ciprofloxacin

    Newsletter Article 27 January 2013 Pages: 5 - 5

24. Cisplatin

    Newsletter Article 27 January 2013 Pages: 5 - 5

25. Cyclosporin

    Newsletter Article 27 January 2013 Pages: 5 - 5

26. Diazepam

    Newsletter Article 27 January 2013 Pages: 5 - 6

27. Dinoprostone

    Newsletter Article 27 January 2013 Pages: 6 - 6

28. Dipivefrine

    Newsletter Article 27 January 2013 Pages: 6 - 6

29. Enalapril

    Newsletter Article 27 January 2013 Pages: 6 - 6

30. Erythromycin

    Newsletter Article 27 January 2013 Pages: 6 - 6

31. Ethinylestradiol

    Newsletter Article 27 January 2013 Pages: 6 - 6

32. Fluconazole

    Newsletter Article 27 January 2013 Pages: 6 - 6

33. Haloperidol

    Newsletter Article 27 January 2013 Pages: 6 - 6

34. Haloperidol/chlorpromazine

    Newsletter Article 27 January 2013 Pages: 7 - 7

35. Hypolipaemics

    Newsletter Article 27 January 2013 Pages: 7 - 7

36. Ifosfamide

    Newsletter Article 27 January 2013 Pages: 7 - 7

37. Interferon alpha

    Newsletter Article 27 January 2013 Pages: 7 - 7

38. Josamycin see Theophylline interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

39. Lidocaine see Prilocaine + lidocaine

    Newsletter Article 27 January 2013 Pages: 7 - 7

40. Lithium interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

41. Minocycline

    Newsletter Article 27 January 2013 Pages: 7 - 7

42. Neuromuscular blockers see Thiopental sodium/neuromuscular blockers

    Newsletter Article 27 January 2013 Pages: 7 - 7

43. Nortriptyline

    Newsletter Article 27 January 2013 Pages: 7 - 8

44. NSAIDs

    Newsletter Article 27 January 2013 Pages: 8 - 8

45. Prilocaine + lidocaine

    Newsletter Article 27 January 2013 Pages: 8 - 8

46. Tetrazepam

    Newsletter Article 27 January 2013 Pages: 8 - 8

47. Theophylline interaction

    Newsletter Article 27 January 2013 Pages: 8 - 8

48. Thiopental sodium/neuromuscular blockers

    Newsletter Article 27 January 2013 Pages: 8 - 8

49. Tobramycin

    Newsletter Article 27 January 2013 Pages: 8 - 8

50. Tranylcypromine

    Newsletter Article 27 January 2013 Pages: 8 - 8